Canada markets closed

Swedish Orphan Biovitrum AB (publ) (SWOBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
13.480.00 (0.00%)
At close: 11:57AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
17,696,000
22,123,000
18,790,000
15,529,000
15,261,000
Cost of Revenue
4,484,000
4,995,000
4,776,000
3,484,000
3,225,000
Gross Profit
13,212,000
17,128,000
14,014,000
12,045,000
12,036,000
Operating Expenses
Research Development
2,265,000
2,796,000
2,354,000
1,994,000
1,594,000
Selling General and Administrative
7,550,000
10,161,000
7,847,000
6,294,000
5,981,000
Total Operating Expenses
9,735,000
12,948,000
10,169,000
8,258,000
7,573,000
Operating Income or Loss
3,477,000
4,180,000
3,845,000
3,787,000
4,463,000
Interest Expense
-
1,111,000
458,000
419,000
454,000
Income Before Tax
2,978,000
2,954,000
3,321,000
3,295,000
4,217,000
Income Tax Expense
485,000
546,000
683,000
616,000
972,000
Income from Continuing Operations
2,493,000
2,408,000
2,638,000
2,679,000
3,245,000
Net Income
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
Net Income available to common shareholders
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
Basic EPS
4.46
3.73
4.26
4.34
5.26
Diluted EPS
4.42
3.69
4.22
4.31
5.21
Basic Average Shares
620,786
645,318
618,955
617,797
616,974
Diluted Average Shares
626,858
651,935
624,910
621,458
623,218